mizuho's jared holz on drug price negotiations: more difficult for industry to get better medicines
Published 10 months ago • 42K plays • Length 6:57
Download video MP4
Download video MP3
Similar videos
-
4:08
weight loss drug market is just beginning to take off, says mizuho's jared holz
-
5:53
mizuho's jared holz talks roche shares surging on glp-1 data
-
4:25
people are 'scratching and clawing' for negative narrative around obesity drugs: mizuho's jared holz
-
5:47
drugs for obesity are a massive market, says mizuho's jared holz
-
5:09
biogen has been an 'uninvestable' stock for awhile, says mizuho's jared holz
-
5:05
pfizer is far behind weight loss drug race despite pill trial, says mizuho's jared holz
-
4:31
blocking the horizon-amgen deal will be worse for pharma than for biotech, says mizuho's jared holz
-
5:13
obesity drug enthusiasm can continue in 2024: mizuho's jared holz
-
2:55
what it takes to build a $4.8 billion biotech company | forbes
-
19:35
pfizer ceo on sales, m&a, mrna, weight loss drug
-
5:56
three-stock lunch: apple, pfizer and delta air lines
-
4:54
merck's challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says jared holz
-
5:12
structure therapeutics is a 'no-brainer takeout' target, says mizuho's jared holz
-
3:14
election noise may make pharmaceutical stocks 'untenable' for investors, says mizuho's jared holz
-
6:08
eli lilly's dtc obesity drug push 'not necessarily an industry game changer': mizuho's jared holz
-
5:26
obesity drug supply-demand imbalance is working in novo nordisk's favor: mizuho's jared holz
-
4:13
mizuho's jared holz on finding opportunities in the biotech space
-
5:52
expectations for pfizer have been low, says mizuho's jared holz on weight-loss pill setback
-
3:56
it doesn't seem like there's too much momentum for healthcare stocks, says mizuho's jared holz
-
3:25
mizuho's jared holz on novo nordisk: there's not much upside near-term
-
5:47
zealand's obesity drug shouldn't disrupt novo nordisk-eli lilly leadership: mizuho's jared holz
-
7:36
white house unveils first 10 drugs subject to medicare price negotiations
Clip.africa.com - Privacy-policy